Joseph H Wender's Insider Trades & SAST Disclosures
Joseph H Wender's most recent trade in Ionis Pharmaceuticals Inc was a trade of 4,677 Restricted Stock Unit done . Disclosure was reported to the exchange on July 15, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Joseph H Wender.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2024 | 4,677 | 4,079 | - | - | Restricted Stock Unit | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2024 | 4,677 | 132,756 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 10,111 | 10,111 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 4,079 | 8,756 | - | - | Restricted Stock Unit | |
| Outfront Media Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2024 | 9,863 | 0 | - | - | Restricted Share Units | |
| Outfront Media Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2024 | 9,863 | 58,732 (0%) | 0% | 0 | Common Stock | |
| Outfront Media Inc | Joseph H. Wender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 624 | 59,356 (0%) | 0% | 0 | Common Stock | |
| Outfront Media Inc | Joseph H. Wender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 10,125 | 10,125 | - | - | Restricted Share Units | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.53 per share. | 09 May 2024 | 16,000 | 128,079 (0%) | 0% | 35.5 | 568,480 | Common Stock |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2024 | 16,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2023 | 5,333 | 4,677 | - | - | Restricted Stock Unit | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2023 | 5,333 | 112,079 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2023 | 1,777 | 106,746 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2023 | 1,777 | 10,010 | - | - | Restricted Stock Unit | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 10,321 | 10,321 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 4,677 | 11,787 | - | - | Restricted Stock Unit | |
| Outfront Media Inc | Joseph H. Wender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 9,863 | 9,863 | - | - | Restricted Share Units | |
| Outfront Media Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 7,290 | 48,293 (0%) | 0% | 0 | Common Stock | |
| Outfront Media Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 7,290 | 0 | - | - | Restricted Share Units | |
| Outfront Media Inc | Joseph H. Wender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 576 | 48,869 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 5,333 | 9,775 | - | - | Restricted Stock Unit | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 5,333 | 102,304 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 2,665 | 104,969 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 2,665 | 7,110 | - | - | Restricted Stock Unit | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 12,000 | 12,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 5,333 | 15,108 | - | - | Restricted Stock Unit | |
| Outfront Media Inc | Joseph H. Wender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 7,290 | 7,290 | - | - | Restricted Share Units | |
| Outfront Media Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2022 | 4,907 | 0 | - | - | Restricted Share Units | |
| Outfront Media Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2022 | 4,907 | 40,802 (0%) | 0% | 0 | Common Stock | |
| Outfront Media Inc | Joseph H. Wender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 201 | 41,003 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 5,333 | 93,638 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 5,333 | 13,108 | - | - | Restricted Stock Unit | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 1,778 | 9,775 | - | - | Restricted Stock Unit | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 1,778 | 96,971 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 889 | 94,527 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 889 | 12,219 | - | - | Restricted Stock Unit | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 666 | 95,193 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 666 | 11,553 | - | - | Restricted Stock Unit | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 12,000 | 12,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 5,333 | 18,441 | - | - | Restricted Stock Unit | |
| Outfront Media Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2021 | 6,366 | 0 | - | - | Restricted Share Units | |
| Outfront Media Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2021 | 6,366 | 35,895 (0%) | 0% | 0 | Common Stock | |
| Outfront Media Inc | Joseph H. Wender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 4,907 | 4,907 | - | - | Restricted Share Units | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.47 per share. | 16 Sep 2020 | 11,250 | 88,305 (0%) | 0% | 28.5 | 320,288 | Common Stock |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2020 | 11,250 | 0 | - | - | Director Stock Option (right to buy) | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2020 | 11,250 | 0 | - | - | Director Stock Option (right to buy) | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.94 per share. | 16 Sep 2020 | 11,250 | 77,055 (0%) | 0% | 12.9 | 145,575 | Common Stock |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2020 | 12,000 | 12,000 | - | - | Director Stock Option (right to buy) | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2020 | 5,333 | 5,333 | - | - | Restricted Stock Units | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2020 | 1,778 | 64,249 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2020 | 1,778 | 5,332 | - | - | Restricted Stock Units | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2020 | 889 | 65,138 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2020 | 889 | 1,777 | - | - | Restricted Stock Units | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2020 | 667 | 666 | - | - | Restricted Stock Units | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2020 | 667 | 65,805 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2020 | 666 | 62,471 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharmaceuticals Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2020 | 666 | 0 | - | - | Restricted Stock Units | |
| Outfront Media Inc | Joseph H. Wender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2020 | 6,366 | 6,366 | - | - | Restricted Share Units | |
| Outfront Media Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2020 | 4,610 | 29,217 (0%) | 0% | 0 | Common Stock | |
| Outfront Media Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2020 | 4,610 | 0 | - | - | Restricted Share Units | |
| Outfront Media Inc | Joseph H. Wender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2020 | 312 | 29,529 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges